​

Aytu BioPharma Ownership | Who Owns Aytu BioPharma?

OverviewRevenueFinancialsChartTranscripts

Aytu BioPharma Ownership Summary

Aytu BioPharma is owned by 30.59% institutional investors, 2.81% insiders, and 66.60% retail investors. Sjs investment consulting is the largest institutional shareholder, holding 0% of AYTU shares. Philotimo Focused Growth and Income is the top mutual fund, with 2.11% of its assets in Aytu BioPharma shares.

AYTU Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAytu BioPharma30.59%2.81%66.60%
SectorHealthcare Stocks 279.42%10.64%-190.05%
IndustrySpecialty & Generic Drug Manufacturers Stocks2774.71%11.85%-2686.56%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Sjs investment consulting---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Sjs investment consulting---

Top Buyers

HolderShares% AssetsChange
Sjs investment consulting---5.00

Top Sellers

HolderShares% AssetsChange
Sjs investment consulting---5.00

Sold Out

HolderChange
Sjs investment consulting-5.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202528-1,876,599-0.22%303.25%11-8.33%2-60.00%
Dec 31, 20242821.74%1,880,741-8.18%303.97%12140.00%5-28.57%
Sep 30, 202423-14.81%2,048,299-0.27%272.02%5-50.00%716.67%
Jun 30, 2024273.85%2,053,77514.39%373.52%10-16.67%620.00%
Mar 31, 20242618.18%1,795,4641.48%323.16%1220.00%5-16.67%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Philotimo Focused Growth and Income189.21K2.11%189.21K
Fidelity Extended Market Index31.99K0.36%-
Vanguard Institutional Extnd Mkt Idx Tr27.89K0.31%-
Spartan Extended Market Index Pool E11.89K0.19%280.00
Spartan Extended Market Index Pool F12.20K0.14%-
Fidelity Series Total Market Index8.05K0.09%-
Northern Trust Extended Eq Market Idx6.31K0.07%-
NT Ext Equity Mkt Idx Fd - L6.31K0.07%-
Dimensional US Sustainability Core 1 ETF3.85K0.06%-
DFA US Targeted Value I3.66K0.06%-5.01K

Recent Insider Transactions

DateNameRoleActivityValue
Jun 09, 2025Disbrow Jarrett Chief Business OfficerBuy$25.00K
Jun 09, 2025Disbrow Joshua R. Chief Executive OfficerBuy$100.00K
Jun 06, 2025Nantahala Capital Management, LLC-Buy$400.00
Feb 28, 2025Disbrow Joshua R. Chief Executive OfficerBuy$19.50K
Jun 16, 2023PYSZCZYMUKA GREG Chief Commerical OfficerBuy$22.43K

Insider Transactions Trends

DateBuySell
2025 Q23-
2025 Q11-
2024 Q4--
2024 Q3--
2024 Q2--

AYTU Ownership FAQ

Who Owns Aytu BioPharma?

Aytu BioPharma shareholders are primarily institutional investors at 30.59%, followed by 2.81% insiders and 66.60% retail investors. The average institutional ownership in Aytu BioPharma's industry, Specialty & Generic Drug Manufacturers Stocks, is 2774.71%, which Aytu BioPharma falls below.

Does Blackrock own Aytu BioPharma?

BlackRock is not among the top 10 institutional shareholders of Aytu BioPharma.

Who is Aytu BioPharma’s biggest shareholder by percentage of total assets invested?

Sjs investment consulting is Aytu BioPharma’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Aytu BioPharma shares, valued at 0$.

Who is the top mutual fund holder of Aytu BioPharma shares?

Philotimo Focused Growth and Income is the top mutual fund holder of Aytu BioPharma shares, with 2.11% of its total shares outstanding invested in 189.21K Aytu BioPharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools